Alberta Investment Management Corp boosted its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 254,612 shares of the medical device company’s stock after purchasing an additional 9,000 shares during the quarter. Alberta […]
Stephens Investment Management Group LLC increased its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 613,923 shares of the medical device company’s stock after buying an additional 661 shares during the period. DexCom comprises approximately 1.2% […]
Moore Capital Management LP increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 129.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 137,547 shares of the medical device company’s stock after buying an additional 77,547 shares during the period. Moore Capital […]
Blue Whale Capital LLP reduced its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 18.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 316,500 shares of the medical device company’s stock after selling 70,000 shares during the period. DexCom comprises […]
DexCom (NASDAQ:DXCM – Free Report) had its price objective lowered by UBS Group from $175.00 to $138.00 in a report released on Wednesday morning, MarketBeat.com reports. The brokerage currently has a buy rating on the medical device company’s stock. DXCM has been the subject of a number of other research reports. StockNews.com started coverage on […]